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Introduction 
HTLV-1 Tax 
Human T-lymphotropic Virus Type 1 (HTLV-1) is a human oncogenic retrovirus that is 
the disease agent of adult T-cell leukemia/lymphoma. It was the first human retrovirus 
discovered (15), and remains of significant scientific interest. The mechanism of HTLV-1-
induced cellular transformation is not yet completely understood, but it has been confirmed that 
of the 14 proteins that are encoded in the genome, Tax is the one that seems to be responsible for 
the pleiotropic effects that an HTLV-1 infection can have on susceptible cells. Tax is a 351-amino 
acid, 40-kDa phosphoprotein (3; 18) that functions as a transcriptional activator of the viral 
genes by recruiting transcriptional coactivators to the long terminal repeats flanking the HTLV-1 
genome (8). Structurally, Tax contains a nuclear import and nuclear export signal, numerous 
leucine zipper-like sequences and other DNA-binding sites (3), along with a suspected 
dimerization domain and a domain responsible for gene transactivation. 
 
(adapted from Alefantis et al., 2007) 
 
In the cell, Tax is mainly localized in nuclear and perinuclear speckles, and it also 
colocalizes with the centrosomes (2). Expression of Tax alone is sufficient to induce detrimental 
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changes in normal T-cells, especially centrosome overamplification (2), aneuploidy, 
chromosomal instability and micronucleation of cells (11). It is possible that these changes may 
lead to cellular transformation; however, the exact mechanism of development of the adult T-cell 
leukemia remains to be elucidated. 
Interestingly, when Tax is introduced into human transformed cells (e.g. HeLa), it shows 
propensity for drastically deregulating the cell cycle. Findings of Liu et al. (10) indicate that Tax 
directly interacts with the APC/C
Cdc20
, causing a number of cellular events that in the long run 
commit the cells to senescence and cause growth arrest. Tax binds and activates APC/C ahead of 
its regular schedule in the cell cycle, causing premature degradation of cyclin A, cyclin B1, 
securin and Skp2 during S phase (8; 11). Reduction in the levels of these regulators causes the 
cells to go through an erroneous cell division cycle and become permanently growth-arrested in 
G1 phase. Cells in this condition are virtually undistinguishable from cells in senescence (8). The 
fact that this effect of Tax can only be observed in transformed cells (and, incidentally, in S. 
cerevisiae cells) makes it an important topic in cancer research. 
Although Tax-induced senescence is phenotypically identical to natural cellular 
senescence, it operates via a different mechanism. Tumor suppressors pRb and p53 are known to 
be involved in natural cellular senescence (6). However, Tax-induced senescence can occur in 
HeLa cells, which lack these functioning tumor suppressors (8). It is likely that some other 
proteins need to be mutated in order to allow Tax infection without inducing senescence. 
Cells lacking functioning p27
Kip1
 protein can maintain Tax without experiencing 
senescence (8). A proposed mechanism for Tax-induced senescence is as follows: after initiating 
expression Tax prematurely activates the APC/C (possibly by binding the Cdc20 subunit); in 
consequence, Skp2 becomes polyubiqutylated and is degraded from S phase onwards, and 
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SCF
Skp2
 becomes inactivated due to lack of available Skp2. In the end, p21C1p1/WAF1 and 
p27
Kip1
 are stabilized, and this process commits a cell to senescence (11). Finding out whether 
Tax and Cdc20 physically interact could help verify this theory. 
Point mutations of Tax have been assayed for comparison against wildtype activity (11). 
The phenotypes suggested that the growth arrest binding domain of Tax is different and separate 
from the transactivation and cell-signaling domains. The location of the APC/C binding domain 
of Tax is yet to be determined. Tax is thought to bind the APC/C
Cdc20
 directly, because these two 
proteins were shown to co-immunoprecipitate (10). Considering this and the surprising 
information that Tax induces senescence in both yeast and human cells, it would be logical for 
the Cdc20 subunit to be a highly conserved protein. In support of this theory, a BLASTP v.2.2.18 
sequence alignment of Saccharomyces cerevisiae (accession no. BAA03957.1) and Homo 
sapiens Cdc20 protein (accession no. AAH00624.1) revealed 35% identity and 54% similarity 
(see figure below, generated using CLC Free Workbench). S. cerevisiae, as the simplest 
eukaryotes, are a good model for studying the cell cycle, and with the addition of the fact that 
Tax induces growth arrest phenotype in yeast cells, they are an important subject of Cdc20 
studies. 
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Anaphase-Promoting Complex/Cyclosome (APC/C) 
The anaphase-promoting complex/cyclosome (APC/C) is an E3 ubiquitin ligase that 
serves the function of the master regulator of the metazoan cell cycle. It is a multi-subunit 
protein whose main enzymatic activity is ubiquitylation of other proteins. Ubiquitylation is a 
process of covalent attachment of small, 76-amino acid, 8.5 kDa protein moieties called ubiquitin 
onto specific lysine residues of the target protein (17). Addition of only a couple of ubiquitin 
molecules can have an important role in signaling and post-translational modifications of some 
proteins; however, addition of four or more units is termed polyubiquitylation and targets the 
protein for degradation by the 26S proteasome (16). This is exactly the pathway via which 
APC/C fulfills its most prominent role in the cell: regulation of progression through the cell 
cycle. 
 
The cell cycle phases are shown on the diagram above. The most heavily regulated points 
in the cycle are termed the checkpoints, and their function is to halt the cell cycle before 
progression into the next phase until all the processes occurring in the previous phase have been 
completed. In case of the APC/C, the checkpoint of most interest is the one that regulates 
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progression from prometaphase into anaphase (see diagram below). During mitosis, the APC/C 
exists as two different complexes: APC/C
Cdc20
 (when bound to the activator cell division cycle 20 
homolog, or Cdc20), and APC/C
Cdh1
 (when associated with the activator Cdh1). The APC/C
Cdh1
 
is responsible for regulating exit from mitosis, and is also involved in G1 and possibly G2 phase. 
Cdc20 is a 55 kDa protein that plays a major role in the regulation of the cell cycle through its 
association with and activation of APC/C during prometaphase and metaphase. Upon attachment 
of the kinetochores to their respective spindle poles, Cdc20 binds the APC/C in order to initiate 
anaphase (12). Cdc20 is usually kept away during prophase and metaphase by the mitotic 
checkpoint complex (MCC) in order to prevent its premature release. In prometaphase, cyclin-
dependent kinase 1 (Cdk1) is activated by cyclin B and phosphorylates proteins needed for 
mitosis (13). Afterwards, APC/C
Cdc20
 starts targeting cyclin B for degradation throughout 
anaphase and telophase. After the degradation is complete, Cdk1 becomes deactivated (5; 7; 14). 
This process is necessary to exit mitosis (13). 
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(adapted from Heilman, 2006 by Oliver J. Salmon)
The APC/C
Cdc20
 also initiates the main event of anaphase: the rapid, total and irreversible 
separation of sister chromatids. It polyubiquitylates securin, a protein inhibitor of the cysteine 
protease separase (14). Upon securin degradation, separase is activated and degrades a protein 
complex called cohesin. The breakdown of cohesin initiates the separation of sister chromatids. 
However, it has been determined that the degradation of cohesin alone is not sufficient to ensure 
proper chromosome separation. 
Current Study 
The suspected interaction of APC/C activator Cdc20 with the HTLV-1 protein Tax make 
it an important target of scientific investigation. The goal of this study is to create a genomically 
tagged version of the cdc20 gene, so that the protein is expressed with an easily detectable 
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epitope tag covalently attached to it. Tagged Cdc20 will then be used in protein-protein 
interaction studies, like immunoprecipitation, to determine whether it indeed directly interacts 
with Tax. 
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Materials and Methods 
PCR 
Genomic recombination constructs were generated via PCR using Phusion High-Fidelity 
DNA Polymerase (Cat. No. F-530, 20U at 2U/µl) and Phusion HF Buffer at 98°C for 4 min, then 
30 cycles of 95°C for 30 sec, 55°C for 30 sec, and 72°C for 1.5 min. Plasmid pFA6a-
GFP(S65T)-TRP1 (9) was used as a template. The forward primer (see sequences below) was 
designed to anneal to the beginning of the TADH1 region (regular font) and contained the last 40 
nt. from cdc20 3’ end excluding the stop codon (italics), and 27-nucleotide HA epitope sequence 
(bold font) ending with a TGA stop codon (underlined). The reverse primer was designed to 
anneal to the 3’ end of the TRP1 gene on the plasmid template and contained 40 nt. of reverse 
complementary sequence to the beginning of the 5’ UTR of the cdc20 gene (italics). The PCR 
products were resolved on a 0.9% agarose gel, bands were excised and purified with a gel 
purification kit (Promega Wizard Cat No. A7170) according to the manufacturer’s protocol. 
 
S. cerevisiae Transformation and Growth 
12 µl of the PCR product was transformed into Y187 strain of S. cerevisiae using a 
lithium acetate protocol (resuspension in 100mM LiOAc; transformation in 34% w/v PEG, 1M 
LiOAc, 0.14mg/ml single-stranded carrier DNA). The starter culture (50ml) was incubated with 
shaking at 30°C overnight and the large-scale culture (300ml) was incubated with shaking at 
30°C until the absorbance at 600nm reached 0.6. 150µl of the transformation product (pellet 
resuspended in 300µl of sterile H2O) was plated and selected on tryptophan deficient (Trp
-
) YPD 
5'-TACAAGGAGGCCCTCTAGTACCAGCCAATATTTGATCAGGTATCCATATGATGTCCCAGATTATGCT 
   TGAGGCGCGCCACTTCTAAA-3' (forward) 
5'-ATTATATGCCTTGACATGAACTTTTATTTTTTTTATTTTAGAATTCGAGCTCGTTTAAAC-3' (reverse) 
12 
 
plates (1% w/v yeast extract, 2% peptone, 2% glucose/dextrose, 2% agar). Several transformants 
were selected and replated to re-confirm selection. 
Yeast Colony PCR 
To confirm the correct recombination locus, PCR was performed using a forward primer 
(see sequences below) that annealed approximately 500 nt from 3’ end of cdc20 gene, and 
reverse primers that annealed either within the TADH region, or within the trp1 gene, using Taq 
polymerase with Novagen 10X NovaTaq Buffer with MgCl2 (Cat. No. 71037) at 95°C for 2 min, 
then 40 cycles of 95°C for 30 sec, 50°C for 30 sec, and 60°C for 4 min. The PCR products were 
resolved on a 0.9% agarose gel. 
 
Western Blot 
Cellular extracts were prepared by cracking the yeast cells by vortexing at top speed for 
10 minutes with glass beads, and  resuspending the cells in SDS-containing 6X protein loading 
buffer (300mM Tris-HCl, ph 6.8; 0.01% w/v bromophenol blue; 15% glycerol; 6% w/v SDS; 
0.01% β-mercaptoethanol). Protein samples were resolved on a 12% polyacrylamide gel, and 
transferred via a wet transfer for 1 hour at 200mA onto a nitrocellulose membrane using a Bio-
Rad apparatus. TBS buffer composition: 25mM Tris-HCl; 137mM NaCl; 2.7µM KCl; pH 
adjusted to 7.2 with 6M HCl. The membrane was blocked using 5% milk solution in TBS-T 
(TBS, 0.5% Tween-20). First blot was performed with mouse anti-HA primary antibody diluted 
in TBS-T (for one hour on an agitator) and then washed 5 times for at least 5 minutes in TBS-T. 
Afterwards a second blot was performed using an α-mouse secondary antibody diluted in TBS-T 
5’-ACAGGTGCACGAGTTGGCTC-3’ (forward) 
5’-TTTAGAAGTGGCGCGCC-3’ (TADH  reverse) 
5’-TACATCAACACCAATAACGCC-3’ (trp1 reverse) 
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(for one hour on an agitator), and then washing 5 times for at least 5 minutes in TBS-T and 2 
times for at least 5 minutes in TBS. The bands were developed for 1 minute in ECL reagent from 
Pierce (Cat. No. 34077) under a covering and then exposed to film in the dark room. 
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Results 
In order to establish a yeast strain with genomically tagged Cdc20 protein, genomic 
recombination constructs were generated using PCR, consisting of the cdc20 gene, a 27-
nucleotide sequence coding for a 9-amino acid hemagglutinin (HA) epitope, and a 40-nucleotide 
homologous recombination arms at each end. PCR was performed from a pFA6a-GFP(S65T)-
TRP1 plasmid template to obtain a linear product engineered to contain both arms of 
homologous recombination in the cdc20 locus on S. cerevisiae chromosome VII (as shown in 
Figure 1A). Primers were designed to anneal at the 5’ end of the TADH1 region (forward) and at 
the 3’ end of the trp1 gene (reverse). 
The finished product consisted of a 40-nucleotide sequence from the 3’ end of the cdc20 
gene without the stop codon (the left arm of homologous recombination), a 27-nucleotide HA tag 
sequence, a stop codon, an ADH1 terminator sequence, trp1 gene sequence, and first 40 
nucleotides of the 3’ untraslated region of the cdc20 gene (the right arm of homologous 
recombination) (see Figure 1B). TADH1 is responsible for correct termination of the cdc20 
construct and for expression of the trp1 gene, which in turn is necessary for subsequent selection 
of successful recombinants. 
In order to obtain a genomically recombined yeast strain, the PCR product obtained 
above was transformed into S. cerevisiae strain Y187 using lithium acetate protocol. The yeast 
genome was expected to homologously recombine with the PCR construct at the sites flanking 
the original stop codon (TGA) at the cdc20 C terminus (as shown in Figure 1C). After 
recombination, the yeast genome was expected to contain the PCR construct incorporated 
seamlessly into the sequence of chromosome VII at the cdc20 locus (Figure 1D). 
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Figure 1. S. cerevisiae genomic recombination. This figure depicts the steps leading to 
obtaining genomically tagged S. cerevisiae. (A) PCR was performed from a plasmid template to 
obtain a linear product engineered to contain both arms of homologous recombination in the 
cdc20 locus on S. cerevisiae chromosome VII. (B) The finished product. (C) The PCR product 
was transformed into S. cerevisiae strain Y187. (D) Yeast genome after recombination. *40-nt. 
stretch of homologous sequence. **40-nt. stretch of reverse complement sequence. 
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In order to verify that genomic recombination took place, yeast colonies were screened 
for trp1 gene presence by using Trp
-
 selection; transformants were plated on tryptophan-deficient 
dropout media and incubated for 36 hours. Multiple recombinants were able to grow after plating 
on Trp
-
 media, which suggests that the recombination was successful. Seven of the largest 
colonies from the screening plates were re-streaked on a common plate and incubated for 36 
hours for growth rate comparison and to confirm the selection (see Figure 2, panels 1-7). Panel 8 
contains the parental strain Y187, which was not transformed with the PCR product and did not 
survive the selection due to the lack of trp1 gene. 
In order to determine presence of HA epitope tag in the positive yeast recombinants, a 
western blot was performed using a mouse hemagglutinin antibody and an α-mouse antibody.  
Strong specific signal was obtained in all lanes, containing recombinants 1-7 (corresponding to 
panels 1-7 from Figure 2). The probes detected a protein of a size appropriate for Cdc20 bound 
to the HA tag. 
Yeast colony PCR was also performed in order to confirm the correct localization of the 
tag at the 3’ end of the cdc20 gene, using primers designed to anneal within the cdc20 locus 
(forward), and either within TADH1 or trp1 region (reverse) in order to amplify a continuous 
stretch of sequence incorporating cdc20 c terminus with the HA tag and TADH1 and trp1 gene 
(data not shown). The PCR conditions need to be readjusted and the experiment repeated. 
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Figure 2. S. cerevisiae transformation and TRP1 selection. Transformed Y187 S. cerevisiae 
were plated on Trp- dropout media to select for stable genomic recombination. Positive 
transformants were selected (as seen in panels 1-7). Panel 8 contains the untransformed parental 
strain Y187, which did not survive the selection. 
 
 
Figure 3. Western blot detecting HA epitope tag. A western blot was performed to determine 
the presence of HA epitope tag in the positive yeast recombinants. Strong specific signal was 
obtained in all lanes, representing recombinants 1-7 (as in Figure 2). The probe detected a protein 
of size appropriate for Cdc20 bound to the HA tag. 
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Discussion 
A yeast strain with genomically tagged Cdc20 protein was established in order to 
facilitate interaction studies between Cdc20 and HTLV-1 protein Tax. It can be inferred that 
tagging Cdc20 on the C terminus with a small epitope tag does not affect its binding to the 
APC/C and normal cell cycle regulation is retained, because viable phenotype was obtained in 
the recombinants, as can be determined from growth visible in Figure 2 panels 1-7. This is an 
important finding, because some sources (e.g. the Yeast GFP Fusion Localization Database 
maintained by UCSF) have indicated that placing a large tag on the C terminus of Cdc20 does 
not yield a viable phenotype. This effect is most likely caused by the tag disrupting or masking 
the region responsible of binding of Cdc20 to the APC/C, which in turn makes cell cycle 
progression impossible and leads to cell arrest and death. A small tag like hemagglutinin, on the 
other hand, does not seem to be disrupting normal Cdc20 function. 
Trp
-
 selection was successfully obtained, as seen in Figure 2; therefore the metabolic 
marker is present in the cells and integrated into the genome. Stable integration is confirmed by 
the fact that the resistant phenotype was passed on to the daughter cells and an abundance of 
colonies was observed. Yeast colony PCR was attempted to confirm the integration at the correct 
locus, but it will need to be repeated after optimizing the conditions. 
Strong specific signal on the western blot in Figure 3, lanes 1-7 confirms that HA epitope 
tag is present in the cells, and shows that it is covalently bound to a much larger protein, since by 
itself the tag would be too small to be visible on the gel. This protein is most likely Cdc20, since 
the genomic tagging construct was specifically engineered to append an HA epitope to the C 
terminus of Cdc20. The protein runs on a polyacrylamide gel at a size approximately appropriate 
for Cdc20 combined with the HA tag. Lane 4 shows a weaker signal that all the other lanes, 
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which could be due to a difference in the quality of yeast cell extracts used for the experiment. 
After the correct recombination locus is confirmed using yeast colony PCR, the HA-
tagged Cdc20 will be useful for association studies with HTLV-1 protein Tax. Previous genetic 
experiments in S. cerevisiae showed that Tax binds APC/C
Cdc20
 and suggested that Cdc20 can be 
the main association target. Co-immunoprecipitation (co-IP) studies using hemagglutinin and 
Tax antibodies should be able to determine whether Tax in fact directly binds to Cdc20. In order 
to perform such studies, the yeast strain with genomically tagged Cdc20 that was created in this 
study would have to be transformed with a plasmid containing Tax under the control of an 
inducible promoter. If the suspicion mentioned above is correct, after inducing Tax expression 
and immunoprecipitating it with a specific antibody a protein gel blotted with HA antibody 
would show strong specific signal close in size to Tax combined with Cdc20, marking the 
presence of hemagglutinin-tagged Cdc20. Such results would provide direct evidence that Tax 
directly interacts with Cdc20 to perform its function and possibly shed more light on the 
mechanism by which Tax is capable of inducing cell cycle arrest. A study like that would be 
further facilitated by creating epitope-tagged Tax constructs and using antibodies against the 
epitope tags, after affirming that tagging Tax does not interfere with its function. 
If Tax does not co-precipitate with Cdc20, then it would suggest that one of the other 
APC/C subunits may be interacting directly with Tax. There are also other possibilities; for 
instance, it’s possible that Tax directly interferes with the correct function of the mitotic 
checkpoint complex (MCC), which consists of Mad2, BubR1 and Bub3 proteins, and whose 
function is to sequester Cdc20 away from the APC/C until anaphase is ready to be initiated (12). 
To confirm this suspicion, co-IP studies of Tax with any of these proteins would need to be 
performed to provide evidence. Another option would be that Tax actively brings and tethers 
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Cdc20 to the APC/C ahead of schedule, either directly or indirectly. Further interaction studies 
would be needed to verify this speculation. Any of these findings will be able to propel forward 
the investigation of Tax-induced senescence and oncogenesis, and will further the understanding 
of the mechanisms by which it interferes with cell cycle regulation. 
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